-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Assumes Avadel Pharmaceuticals at Buy, Announces Price Target of $22

Benzinga·07/18/2025 10:36:29
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju assumes Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy rating and announces Price Target of $22.